H.R. 2276 · 112th Congress

To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Stage
In committee
Sponsor
Debbie Wasserman Schultz
Introduced
2011-06-22
Latest action
2011-08-25 · Referred to the Subcommittee on Intellectual Property, Competition and the Internet.

Subjects

Congressional oversight
Health care costs and insurance
Health care coverage and access
Government studies and investigations
Health care quality
Medical tests and diagnostic methods
Genetics
Commerce
Intellectual property